Department of Emergency Medicine and ‡Davis Heart and Lung Research Institute and Division of Cardiovascular Medicine, Department of Internal Medicine, College of Medicine, The Ohio State University , Columbus, Ohio 43210, United States.
Biochemistry. 2013 Sep 24;52(38):6712-23. doi: 10.1021/bi400404s. Epub 2013 Sep 11.
S-Glutathionylation is a redox-regulated modification that uncouples endothelial nitric oxide synthase (eNOS), switching its function from nitric oxide (NO) synthesis to (•)O2(-) generation, and serves to regulate vascular function. While in vitro or in vivo eNOS S-glutathionylation with modification of Cys689 and Cys908 of its reductase domain is triggered by high levels of glutathione disulfide (GSSG) or oxidative thiyl radical formation, it remains unclear how this process may be reversed. Glutaredoxin-1 (Grx1), a cytosolic and glutathione-dependent enzyme, can reverse protein S-glutathionylation; however, its role in regulating eNOS S-glutathionylation remains unknown. We demonstrate that Grx1 in the presence of glutathione (GSH) (1 mM) reverses GSSG-mediated eNOS S-glutathionylation with restoration of NO synthase activity. Because Grx1 also catalyzes protein S-glutathionylation with an increased [GSSG]/[GSH] ratio, we measured its effect on eNOS S-glutathionylation when the [GSSG]/[GSH] ratio was >0.2, which can occur in cells and tissues under oxidative stress, and observed an increased level of eNOS S-glutathionylation with a marked decrease in eNOS activity without uncoupling. This eNOS S-glutathionylation was reversed with a decrease in the [GSSG]/[GSH] ratio to <0.1. Liquid chromatography and tandem mass spectrometry identified a new site of eNOS S-glutathionylation by Grx1 at Cys382, on the surface of the oxygenase domain, without modification of Cys689 or Cys908, each of which is buried within the reductase. Furthermore, Grx1 was demonstrated to be a protein partner of eNOS in vitro and in normal endothelial cells, supporting its role in eNOS redox regulation. In endothelial cells, Grx1 inhibition or gene silencing increased the level of eNOS S-glutathionylation and decreased the level of cellular NO generation. Thus, Grx1 can exert an important role in the redox regulation of eNOS in cells.
谷胱甘肽化是一种氧化还原调节修饰,它使内皮型一氧化氮合酶(eNOS)解偶联,将其功能从一氧化氮(NO)合成切换为(•)O2(-)生成,从而调节血管功能。虽然体外或体内 eNOS 的 S-谷胱甘肽化通过还原酶结构域中 Cys689 和 Cys908 的修饰,由高水平的谷胱甘肽二硫化物(GSSG)或氧化硫自由基形成触发,但尚不清楚这一过程如何逆转。谷胱甘肽还原酶-1(Grx1)是一种细胞溶质和依赖谷胱甘肽的酶,可以逆转蛋白质 S-谷胱甘肽化;然而,其在调节 eNOS S-谷胱甘肽化中的作用尚不清楚。我们证明,在谷胱甘肽(GSH)(1 mM)存在的情况下,Grx1 可逆转 GSSG 介导的 eNOS S-谷胱甘肽化,恢复一氧化氮合酶活性。因为 Grx1 还可以在 [GSSG]/[GSH] 比值增加的情况下催化蛋白质 S-谷胱甘肽化,所以当 [GSSG]/[GSH] 比值>0.2 时,我们测量了其对 eNOS S-谷胱甘肽化的影响,这种比值可以在细胞和组织的氧化应激下发生,并且观察到 eNOS S-谷胱甘肽化水平增加,而 eNOS 活性明显降低,没有解偶联。这种 eNOS S-谷胱甘肽化在 [GSSG]/[GSH] 比值降低到<0.1 时被逆转。液相色谱和串联质谱鉴定了 Grx1 在氧合酶结构域表面上的 eNOS S-谷胱甘肽化的新位点,该位点位于 Cys382,而不修饰 Cys689 或 Cys908,这两个位点都位于还原酶内。此外,在体外和正常内皮细胞中,Grx1 被证明是 eNOS 的蛋白质伴侣,支持其在 eNOS 氧化还原调节中的作用。在内皮细胞中,Grx1 的抑制或基因沉默增加了 eNOS S-谷胱甘肽化水平,降低了细胞内 NO 生成水平。因此,Grx1 可以在细胞中对 eNOS 的氧化还原调节中发挥重要作用。